Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Telo Genomics Corp (TDSGF)

Telo Genomics Corp (TDSGF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Telo Genomics and Emery Pharma Announce Collaboration Newsfile - Wed May 15, 7:56AM CDT

Toronto, Ontario--(Newsfile Corp. - May 15, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform...

TDSGF : 0.1227 (+1.32%)
TELO.VN : 0.180 (+5.88%)
Telo Genomics Receives Accreditation from College of American Pathologists Newsfile - Wed Apr 10, 7:52AM CDT

Toronto, Ontario--(Newsfile Corp. - April 10, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform...

TDSGF : 0.1227 (+1.32%)
TELO.VN : 0.180 (+5.88%)
Telo Genomics' Flagship MRD Clinical Trial Expands into Multi-Center Trial Newsfile - Tue Apr 2, 7:52AM CDT

Toronto, Ontario--(Newsfile Corp. - April 2, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform...

TDSGF : 0.1227 (+1.32%)
TELO.VN : 0.180 (+5.88%)
Telo Genomics Initiates MRD Clinical Trial for Multiple Myeloma Patients Newsfile - Tue Feb 13, 7:50AM CST

Toronto, Ontario--(Newsfile Corp. - February 13, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") is pleased to announce that it has received the first patient sample for...

TDSGF : 0.1227 (+1.32%)
TELO.VN : 0.180 (+5.88%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030 FinancialNewsMedia - Tue Jan 30, 8:15AM CST

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END

TDSGF : 0.1227 (+1.32%)
TELO.VN : 0.180 (+5.88%)
BMY : 43.37 (-1.50%)
TMO : 594.09 (-0.20%)
NTRA : 106.27 (-0.18%)
NEO : 14.91 (+0.74%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030 GlobeNewswire - Tue Jan 30, 8:15AM CST

TDSGF : 0.1227 (+1.32%)
TELO.VN : 0.180 (+5.88%)
BMY : 43.37 (-1.50%)
TMO : 594.09 (-0.20%)
NTRA : 106.27 (-0.18%)
NEO : 14.91 (+0.74%)
Telo Genomics Engages US Diagnostics Experts to Power Product Adoption in the US Newsfile - Tue Jan 30, 7:56AM CST

Toronto, Ontario--(Newsfile Corp. - January 30, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") is pleased to announce that it has engaged Trusted Health Advisors (THA),...

TDSGF : 0.1227 (+1.32%)
TELO.VN : 0.180 (+5.88%)
Telo Genomics Gears up for American Society of Hematology Conference Newsfile - Wed Dec 6, 2023

Toronto, Ontario--(Newsfile Corp. - December 6, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), (the "Company" or "Telo"), an emerging molecular testing platform provider leveraging...

TDSGF : 0.1227 (+1.32%)
TELO.VN : 0.180 (+5.88%)
Telo Genomics Launches Physician Experience Program in the United States Newsfile - Thu Nov 16, 2023

SMART Observational Study a Critical Step Toward Full Platform AvailabilityToronto, Ontario--(Newsfile Corp. - November 16, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), (the "Company"...

TDSGF : 0.1227 (+1.32%)
TELO.VN : 0.180 (+5.88%)
Telo Genomics Advances to the Final Stage of Accreditation from The College of American Pathologists Newsfile - Tue Nov 7, 2023

An Important Accreditation Milestone Achieved Towards Full Commercial AvailabilityToronto, Ontario--(Newsfile Corp. - November 7, 2023) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3D0A), (the...

TDSGF : 0.1227 (+1.32%)
TELO.VN : 0.180 (+5.88%)

Barchart Exclusives

Is It Too Late to Buy the Best Dow Stock of 2024? Barchart - Mon May 20, 12:09PM CDT
As the Dow Jones reaches record highs and American Express leads the pack, is it too late to snag a piece of the stock? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot